-
Starting this fall, UNT Health Fort Worth will offer a new pharmaceutical sciences PhD program — the first of its kind in North Texas. The school said the new program could help address workforce needs as the life sciences and research and development industries continue to grow in the region.
-
Prism Health North Texas, a community health center, participated in clinical trials for Merck's new HIV treatment, Idvynso. It could help address a drug resistance that's been on the rise in low- and middle-income countries.
-
With just days before open enrollment ends, The Senior Source is helping people avoid scams and make informed choices when enrolling in Medicare or other insurance programs.
-
The same bottles were available in different stores, indicating a “more systematic effort to counterfeit these substances,” says investigative reporter Keri Blakinger.
-
Advocates are gathering in Austin Monday to meet with lawmakers about funding and bills on HIV health care.
-
With little regulation, counterfeit medication is common and may prove to be ineffective, the wrong strength, or contain dangerous ingredients.
-
On Friday, the House sent to President Biden's desk what Democrats call a historic piece of legislation, but it's still a much smaller version of what they — and Biden — originally called for.
-
Pelosi joined Rep. Colin Allred at a health care roundtable to discuss legislation to lower drug prices.
-
The pharmacy says it will bypass health care industry "middlemen" and help consumers avoid high drug prices by charging manufacturers' prices plus a flat 15% markup and pharmacist fee.
-
The government wants consumers to have sticker shock about drug prices. A new rule requires list prices be displayed in TV ads. Patients advocates are not sure it will do much to lower prices.
-
Pharmacy benefit managers are the focus of proposed regulations that could reduce drug costs for seniors and cut profits for middlemen. It could set a precedent for the broader market.
-
U.S. prescriptions for Valium, Ativan and other benzodiazepines have shot up since 2003, statistics show, especially for chronic pain. Roughly half those prescriptions are from primary care providers.